Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 41 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

5 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

N/A
10(43.5%)
Phase 1
6(26.1%)
Phase 4
4(17.4%)
Phase 2
2(8.7%)
Phase 3
1(4.3%)
23Total
N/A(10)
Phase 1(6)
Phase 4(4)
Phase 2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials
NCT06597227Not ApplicableRecruiting

Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy

Role: collaborator

NCT07361783Not ApplicableRecruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

Role: collaborator

NCT07294027Not ApplicableNot Yet Recruiting

ICSI Versus Conventional IVF in Couples With Unexplained Infertility

Role: collaborator

NCT07172035Recruiting

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06280313Recruiting

Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension

Role: collaborator

NCT05983003Completed

Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

Role: collaborator

NCT07003191Active Not Recruiting

Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

Role: collaborator

NCT05955391Phase 2Active Not Recruiting

TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)

Role: collaborator

NCT05329155Not ApplicableCompleted

Early Administration of Heparin At FMC for PPCI of STEMI Patients

Role: collaborator

NCT06458972Recruiting

Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)

Role: collaborator

NCT06662643Not ApplicableActive Not Recruiting

A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection

Role: collaborator

NCT04735861Phase 2Completed

Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma

Role: collaborator

NCT06503094Phase 1Recruiting

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

Role: collaborator

NCT05965362Recruiting

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）

Role: collaborator

NCT05999188Recruiting

Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC)

Role: collaborator

NCT06470256Phase 1Recruiting

Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma

Role: collaborator

NCT05694273Not Yet Recruiting

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

Role: collaborator

NCT06141538Not Yet Recruiting

Response of Intracardiac Thrombus to Anticoagulants in Patients With Non-valvular Atrial Fibrillation (LYSIS)

Role: collaborator

NCT05965375Not Yet Recruiting

Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias

Role: collaborator